These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 26315267)
1. 2-Deoxyglucose induces the expression of thioredoxin interacting protein (TXNIP) by increasing O-GlcNAcylation - Implications for targeting the Warburg effect in cancer cells. Hong SY; Hagen T Biochem Biophys Res Commun; 2015 Oct; 465(4):838-44. PubMed ID: 26315267 [TBL] [Abstract][Full Text] [Related]
2. Mechanistic target of rapamycin (mTOR) dependent regulation of thioredoxin interacting protein (TXNIP) transcription in hypoxia. Wong RW; Hagen T Biochem Biophys Res Commun; 2013 Mar; 433(1):40-6. PubMed ID: 23454121 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of thioredoxin-1 enhances the toxicity of glycolysis inhibitor 2-deoxyglucose by downregulating SLC1A5 expression in colorectal cancer cells. Tang T; Fang D; Ji Z; Zhong Z; Zhou B; Ye L; Jiang L; Sun X Cell Oncol (Dordr); 2024 Apr; 47(2):607-621. PubMed ID: 37867183 [TBL] [Abstract][Full Text] [Related]
4. A potential mechanism of metformin-mediated regulation of glucose homeostasis: inhibition of Thioredoxin-interacting protein (Txnip) gene expression. Chai TF; Hong SY; He H; Zheng L; Hagen T; Luo Y; Yu FX Cell Signal; 2012 Aug; 24(8):1700-5. PubMed ID: 22561086 [TBL] [Abstract][Full Text] [Related]
5. Dose-dependent effect of 2-deoxy-D-glucose on glycoprotein mannosylation in cancer cells. Ahadova A; Gebert J; von Knebel Doeberitz M; Kopitz J; Kloor M IUBMB Life; 2015 Mar; 67(3):218-26. PubMed ID: 25854316 [TBL] [Abstract][Full Text] [Related]
6. Identification of the determinants of 2-deoxyglucose sensitivity in cancer cells by shRNA library screening. Kobayashi H; Nishimura H; Matsumoto K; Yoshida M Biochem Biophys Res Commun; 2015 Nov; 467(1):121-7. PubMed ID: 26403972 [TBL] [Abstract][Full Text] [Related]
7. Roles of thioredoxin binding protein (TXNIP) in oxidative stress, apoptosis and cancer. Zhou J; Chng WJ Mitochondrion; 2013 May; 13(3):163-9. PubMed ID: 22750447 [TBL] [Abstract][Full Text] [Related]
8. 2-Deoxyglucose induces cell cycle arrest and apoptosisin colorectal cancer cells independent of its glycolysis inhibition. Muley P; Olinger A; Tummala H Nutr Cancer; 2015; 67(3):514-22. PubMed ID: 25751508 [TBL] [Abstract][Full Text] [Related]
9. MondoA-Thioredoxin-Interacting Protein Axis Maintains Regulatory T-Cell Identity and Function in Colorectal Cancer Microenvironment. Lu Y; Li Y; Liu Q; Tian N; Du P; Zhu F; Han Y; Liu X; Liu X; Peng X; Wang X; Wu Y; Tong L; Li Y; Zhu Y; Wu L; Zhang P; Xu Y; Chen H; Li B; Tong X Gastroenterology; 2021 Aug; 161(2):575-591.e16. PubMed ID: 33901495 [TBL] [Abstract][Full Text] [Related]
10. Thioredoxin-interacting protein: an oxidative stress-related gene is upregulated by glucose in human prostate carcinoma cells. Pang ST; Hsieh WC; Chuang CK; Chao CH; Weng WH; Juang HH J Mol Endocrinol; 2009 Mar; 42(3):205-14. PubMed ID: 19052253 [TBL] [Abstract][Full Text] [Related]
11. 2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy. Zhang D; Li J; Wang F; Hu J; Wang S; Sun Y Cancer Lett; 2014 Dec; 355(2):176-83. PubMed ID: 25218591 [TBL] [Abstract][Full Text] [Related]
12. Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces beta-cell apoptosis. Minn AH; Hafele C; Shalev A Endocrinology; 2005 May; 146(5):2397-405. PubMed ID: 15705778 [TBL] [Abstract][Full Text] [Related]
13. Glycolysis inhibitor 2-deoxy-D-glucose suppresses carcinogen-induced rat hepatocarcinogenesis by restricting cancer cell metabolism. Wang Z; Zhang L; Zhang D; Sun R; Wang Q; Liu X Mol Med Rep; 2015 Mar; 11(3):1917-24. PubMed ID: 25394852 [TBL] [Abstract][Full Text] [Related]
14. Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells. Ben Sahra I; Laurent K; Giuliano S; Larbret F; Ponzio G; Gounon P; Le Marchand-Brustel Y; Giorgetti-Peraldi S; Cormont M; Bertolotto C; Deckert M; Auberger P; Tanti JF; Bost F Cancer Res; 2010 Mar; 70(6):2465-75. PubMed ID: 20215500 [TBL] [Abstract][Full Text] [Related]
15. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer. Baker AF; Koh MY; Williams RR; James B; Wang H; Tate WR; Gallegos A; Von Hoff DD; Han H; Powis G Pancreas; 2008 Mar; 36(2):178-86. PubMed ID: 18376310 [TBL] [Abstract][Full Text] [Related]
16. mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells. Pusapati RV; Daemen A; Wilson C; Sandoval W; Gao M; Haley B; Baudy AR; Hatzivassiliou G; Evangelista M; Settleman J Cancer Cell; 2016 Apr; 29(4):548-562. PubMed ID: 27052953 [TBL] [Abstract][Full Text] [Related]
17. Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP. Shen L; O'Shea JM; Kaadige MR; Cunha S; Wilde BR; Cohen AL; Welm AL; Ayer DE Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5425-30. PubMed ID: 25870263 [TBL] [Abstract][Full Text] [Related]
18. Silibinin induces metabolic crisis in triple-negative breast cancer cells by modulating EGFR-MYC-TXNIP axis: potential therapeutic implications. Iqbal MA; Chattopadhyay S; Siddiqui FA; Ur Rehman A; Siddiqui S; Prakasam G; Khan A; Sultana S; Bamezai RN FEBS J; 2021 Jan; 288(2):471-485. PubMed ID: 32356386 [TBL] [Abstract][Full Text] [Related]
19. Cytokines Regulate β-Cell Thioredoxin-interacting Protein (TXNIP) via Distinct Mechanisms and Pathways. Hong K; Xu G; Grayson TB; Shalev A J Biol Chem; 2016 Apr; 291(16):8428-39. PubMed ID: 26858253 [TBL] [Abstract][Full Text] [Related]
20. Metabolism-independent sugar effects on gene transcription: the role of 3-O-methylglucose. Minn AH; Couto FM; Shalev A Biochemistry; 2006 Sep; 45(37):11047-51. PubMed ID: 16964965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]